KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Recursion Pharmaceuticals (RXRX) Tax Rate (2023 - 2025)

Recursion Pharmaceuticals' Tax Rate history spans 3 years, with the latest figure at 0.02% for Q4 2025.

  • For Q4 2025, Tax Rate fell 1.0% year-over-year to 0.02%; the TTM value through Dec 2025 reached 0.02%, down 22.0%, while the annual FY2025 figure was 0.02%, 22.0% down from the prior year.
  • Tax Rate reached 0.02% in Q4 2025 per RXRX's latest filing, down from 0.0% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 4.19% in Q4 2023 to a low of 0.17% in Q3 2024.
  • Average Tax Rate over 3 years is 0.68%, with a median of 0.04% recorded in 2025.
  • Peak YoY movement for Tax Rate: plummeted -419bps in 2024, then rose 17bps in 2025.
  • A 3-year view of Tax Rate shows it stood at 4.19% in 2023, then tumbled by -100bps to 0.0% in 2024, then tumbled by -373bps to 0.02% in 2025.
  • Per Business Quant, the three most recent readings for RXRX's Tax Rate are 0.02% (Q4 2025), 0.0% (Q3 2025), and 0.08% (Q1 2025).